Biliary Stents Market Study Explores Industry Growth Toward $0.66 Billion

The biliary stents market is set for significant expansion over the coming years, driven by technological advancements and evolving treatment approaches. This sector is witnessing innovation and increasing adoption across various medical procedures, projecting a promising future. Below is a detailed overview of the market size, key players, emerging trends, and segmentation that define this industry.

Projected Market Growth and Size Overview of the Biliary Stents Market
The biliary stents market is anticipated to experience robust growth, reaching a valuation of $0.66 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 5.6%. Factors fueling this growth include the development of covered and partially covered metal stents, a rising preference for biodegradable polymer stents, the broader use of minimally invasive surgical techniques, heightened awareness about stent-related complications, and the integration of innovative imaging and smart stent technologies. Key trends shaping the market involve increased utilization of self-expandable metal stents (SEMS), growing adoption of biodegradable polymer options, a surge in endoscopic and minimally invasive procedures, expanding applications in pancreatic and gallstone treatments, and a stronger emphasis on stent safety and patient outcomes.

Download a free sample of the biliary stents market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27221&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Main Companies Leading the Biliary Stents Industry
The competitive landscape of the biliary stents market is dominated by several prominent companies including Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton dic*kinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, and M.I Tech.
A significant development occurred in January 2024 when Olympus Corporation, headquartered in Japan, acquired South Korea-based Taewoong Medical Co. Ltd. for $370 million. This strategic purchase is aimed at enhancing Olympus's global portfolio in endoscopic devices by incorporating Taewoong's metallic stents, including biliary stents, thereby strengthening its position in gastrointestinal treatment solutions. Taewoong specializes in self-expandable metallic stents, further complementing Olympus's product offerings.

Emerging Innovations and Trends Impacting the Biliary Stents Market
Industry leaders are prioritizing the creation of advanced biliary stents, such as drug-eluting stents, designed to improve patient outcomes by increasing durability and minimizing complications like restenosis. These specialized stents are coated with medications that gradually release to prevent tissue overgrowth and bile duct blockages.
A recent example is the approval granted in July 2024 by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for biliary ARISTENT, developed by South Korea's CGBIO. This innovative stent features a patented 'HOOK & CROSS' structure that enhances flexibility and long-term patency. It is tailored to conform to the bile duct's shape, reducing the risk of migration and boosting patient comfort. Additionally, its advanced drug-eluting coating helps reduce inflammation and extend the functional life of the stent, offering a more effective treatment option for biliary obstructions.

View the full biliary stents market report:
https://www.thebusinessresearchcompany.com/report/biliary-stents-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Detailed Market Segmentation of the Global Biliary Stents Sector
The biliary stents market is categorized across several dimensions to capture its diverse applications and product types:
- By Type: Metal, Polymer, Plastic
- By Design: Single Stent, Double Stent, Triple Stent
- By Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP), Percutaneous Transhepatic Cholangiography (PTC)
- By Application: Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones, Other Applications
- By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users.

Further subcategories include:
- Metal stents such as Self-Expandable Metal Stents (SEMS), Covered Metal Stents, Uncovered Metal Stents, and Partially Covered Metal Stents.
- Polymer stents divided into Biodegradable and Non-Biodegradable Polymer Stents.
- Plastic stents including Straight Plastic Stents, Double Pigtail Plastic Stents, Multiple Side Hole Stents, Teflon Stents, and Polyurethane Stents.

This structured segmentation highlights the variety and specificity of products and applications within the biliary stents market, reflecting its complexity and growth potential.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.